Correlation Between Korean Drug and Hana Financial

Can any of the company-specific risk be diversified away by investing in both Korean Drug and Hana Financial at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Korean Drug and Hana Financial into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Korean Drug Co and Hana Financial 7, you can compare the effects of market volatilities on Korean Drug and Hana Financial and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Korean Drug with a short position of Hana Financial. Check out your portfolio center. Please also check ongoing floating volatility patterns of Korean Drug and Hana Financial.

Diversification Opportunities for Korean Drug and Hana Financial

-0.66

Correlation Coefficient

Korean Drug  Hana Financial

Excellent diversification

The 3 months correlation between Korean and Hana is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Korean Drug Co and Hana Financial 7 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hana Financial 7 and Korean Drug is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Korean Drug Co are associated (or correlated) with Hana Financial. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hana Financial 7 has no effect on the direction of Korean Drug i.e., Korean Drug and Hana Financial go up and down completely randomly.

Pair Corralation between Korean Drug and Hana Financial

Assuming the 90 days trading horizon Korean Drug Co is expected to under-perform the Hana Financial. But the stock apears to be less risky and, when comparing its historical volatility, Korean Drug Co is 3.45 times less risky than Hana Financial. The stock trades about -0.16 of its potential returns per unit of risk. The Hana Financial 7 is currently generating about 0.26 of returns per unit of risk over similar time horizon. If you would invest  811,000  in Hana Financial 7 on September 15, 2024 and sell it today you would earn a total of  757,000  from holding Hana Financial 7 or generate 93.34% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Korean Drug Co  vs.  Hana Financial 7

Korean Drug

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Korean Drug Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Hana Financial 7

Risk-Adjusted Performance

20 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Hana Financial 7 are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Hana Financial sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Korean Drug and Hana Financial

The main advantage of trading using opposite Korean Drug and Hana Financial positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Korean Drug position performs unexpectedly, Hana Financial can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hana Financial will offset losses from the drop in Hana Financial's long position.

The idea behind Korean Drug Co and Hana Financial 7 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.